Therapeutic Areas: Immunology | Pulmonary/Respiratory Diseases | Vaccines | Infections and Infectious Diseases

Influenza Clinical Trials


A listing of Influenza medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

Alabama

Birmingham : Influence Study Site

A clinical research study of Nitazoxanide and Oseltamivir for the treatment of Influenza

Birmingham : GSK Investigational Site

A clinical trial seeking patients for a research study for the treatment of Influenza, Human

Birmingham : The University of Alabama at Birmingham

Patients are needed to participate in a clinical research study for the treatment of Influenza, Human

Arizona

Phoenix : Southwest Center for HIV/AIDS

Do you have symptoms that may be caused by the flu?

Tucson : Influence Study Site

A clinical research study of Nitazoxanide and Oseltamivir for the treatment of Influenza

Arkansas

Hot Springs : Influence Study Site

A clinical research study of Nitazoxanide and Oseltamivir for the treatment of Influenza

Little Rock : GSK Investigational Site

A clinical trial seeking patients for a research study for the treatment of Influenza, Human

California

El Cajon : Triwest Research Institute

A Phase 2b, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study of 2 Dose Levels of VX-787 Administered as Monotherapy and One Dose Level of VX-787 Administered in Combination With Oseltamivir for the Treatment of Acute Uncomplicated Seasonal Influenza A in Adult Subjects

San Diego : Precision Research Institute

A Phase 2b, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study of 2 Dose Levels of VX-787 Administered as Monotherapy and One Dose Level of VX-787 Administered in Combination With Oseltamivir for the Treatment of Acute Uncomplicated Seasonal Influenza A in Adult Subjects

San Diego : Precision Research Institute

A Phase 2b, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study of 2 Dose Levels of VX-787 Administered as Monotherapy and One Dose Level of VX-787 Administered in Combination With Oseltamivir for the Treatment of Acute Uncomplicated Seasonal Influenza A in Adult Subjects

San Gabriel : California Center for Clinical Research

A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating the Efficacy and Safety of Favipiravir in Adult Subjects with Uncomplicated Influenza

Anaheim : Influence Study Site

A clinical research study of Nitazoxanide and Oseltamivir for the treatment of Influenza

Anaheim : 259, Novartis Investigational Site

Patients are needed to participate in a clinical research study evaluating Adjuvanted Quadrivalent Subunit Influenza Virus Vaccine (aQIV) and Non-adjuvanted Trivalent Influenza Vaccine (TIV) / Quadrivalent Influenza Vaccine (QIV) for the treatment of Influenza Virus

Beverly Hills : Updated

Patients are needed to participate in a clinical research study evaluating oseltamivir and Alternative Control for the treatment of Influenza

Burbank : Updated

Patients are needed to participate in a clinical research study evaluating oseltamivir and Alternative Control for the treatment of Influenza

Chula Vista : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human

Fresno : Influence Study Site

A clinical research study of Nitazoxanide and Oseltamivir for the treatment of Influenza

Harbor City : Influence Study Site

A clinical research study of Nitazoxanide and Oseltamivir for the treatment of Influenza

Huntington Beach : Influence Study Site

A clinical research study of Nitazoxanide and Oseltamivir for the treatment of Influenza

La Mesa : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human

La Puente : 238, Novartis Investigational Site

Patients are needed to participate in a clinical research study evaluating Adjuvanted Quadrivalent Subunit Influenza Virus Vaccine (aQIV) and Non-adjuvanted Trivalent Influenza Vaccine (TIV) / Quadrivalent Influenza Vaccine (QIV) for the treatment of Influenza Virus

Lomita : Influence Study Site

A clinical research study of Nitazoxanide and Oseltamivir for the treatment of Influenza

Los Angeles : Updated

Patients are needed to participate in a clinical research study evaluating oseltamivir and Alternative Control for the treatment of Influenza

Ontario : 411, Novartis Investigational Site

Patients are needed to participate in a clinical research study evaluating Adjuvanted Quadrivalent Subunit Influenza Virus Vaccine (aQIV) and Non-adjuvanted Trivalent Influenza Vaccine (TIV) / Quadrivalent Influenza Vaccine (QIV) for the treatment of Influenza Virus

Sacramento : Updated

Patients are needed to participate in a clinical research study evaluating oseltamivir and Alternative Control for the treatment of Influenza

San Diego : GSK Investigational Site

A clinical trial seeking patients for a research study for the treatment of Influenza, Human

Colorado

Aurora : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human

Aurora : Updated

Patients are needed to participate in a clinical research study of oseltamivir [Tamiflu] to evaluate Influenza

Denver : 249, Novartis Investigational Site

Patients are needed to participate in a clinical research study evaluating Adjuvanted Quadrivalent Subunit Influenza Virus Vaccine (aQIV) and Non-adjuvanted Trivalent Influenza Vaccine (TIV) / Quadrivalent Influenza Vaccine (QIV) for the treatment of Influenza Virus

Thornton : Influence Study Site

A clinical research study of Nitazoxanide and Oseltamivir for the treatment of Influenza

Connecticut

Stamford : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human

District of Columbia

Washington : GSK Investigational Site

A clinical trial seeking patients for a research study for the treatment of Influenza, Human

Florida

Clearwater : Clinical Research of West Florida, Inc.

Are you suffering from flu like symptoms?

Miami : New Horizon Research Center

A Phase 3, Randomized, Double Blind, Placebo-Controlled, Multicenter Study Evaluating the Efficacy and Safety of Favipiravir in Adult Subjects with Uncomplicated Influenza

Tampa : University of South Florida - Tampa General Hospital

A double-blind, randomized, stratified, multi-center trial evaluating conventional and high dose oseltamivir in the treatment of immunocompromised patients with influenza

Coral Gables : Influence Study Site

A clinical research study of Nitazoxanide and Oseltamivir for the treatment of Influenza

Coral Gables : Clinical Research of South Florida

Patients are needed to participate in a clinical research study evaluating Bifidobacterium lactis HN019 and Placebo for the treatment of Influenza

Edgewater : Influence Study Site

A clinical research study of Nitazoxanide and Oseltamivir for the treatment of Influenza

Hialeah : 416, Novartis Investigational Site

Patients are needed to participate in a clinical research study evaluating Adjuvanted Quadrivalent Subunit Influenza Virus Vaccine (aQIV) and Non-adjuvanted Trivalent Influenza Vaccine (TIV) / Quadrivalent Influenza Vaccine (QIV) for the treatment of Influenza Virus

Hollywood : Broward Research Group

A clinical trial seeking patients for a Virus Diseases, RNA Virus Infections, Respiratory Tract Diseases or Respiratory Tract Infections treatment research study

Homestead : 412, Novartis Investigational Site

Patients are needed to participate in a clinical research study evaluating Adjuvanted Quadrivalent Subunit Influenza Virus Vaccine (aQIV) and Non-adjuvanted Trivalent Influenza Vaccine (TIV) / Quadrivalent Influenza Vaccine (QIV) for the treatment of Influenza Virus

Kissimmee : Influence Study Site

A clinical research study of Nitazoxanide and Oseltamivir for the treatment of Influenza

Lauderdale Lakes : Influence Study Site

A clinical research study of Nitazoxanide and Oseltamivir for the treatment of Influenza

Miami : Influence Study Site

A clinical research study of Nitazoxanide and Oseltamivir for the treatment of Influenza

Miami : Miami Research Associates

A clinical trial seeking patients for a Virus Diseases, RNA Virus Infections, Respiratory Tract Diseases or Respiratory Tract Infections treatment research study

Miami : 277,Novartis Investigational Site

Patients are needed to participate in a clinical research study evaluating Adjuvanted Quadrivalent Subunit Influenza Virus Vaccine (aQIV) and Non-adjuvanted Trivalent Influenza Vaccine (TIV) / Quadrivalent Influenza Vaccine (QIV) for the treatment of Influenza Virus

Miami : 417, Novartis Investigational Site

Patients are needed to participate in a clinical research study evaluating Adjuvanted Quadrivalent Subunit Influenza Virus Vaccine (aQIV) and Non-adjuvanted Trivalent Influenza Vaccine (TIV) / Quadrivalent Influenza Vaccine (QIV) for the treatment of Influenza Virus

Orlando : Influence Study Site

A clinical research study of Nitazoxanide and Oseltamivir for the treatment of Influenza

Orlando : 297, Novartis Investigational vaccine

Patients are needed to participate in a clinical research study evaluating Adjuvanted Quadrivalent Subunit Influenza Virus Vaccine (aQIV) and Non-adjuvanted Trivalent Influenza Vaccine (TIV) / Quadrivalent Influenza Vaccine (QIV) for the treatment of Influenza Virus

St. Cloud : Influence Study Site

A clinical research study of Nitazoxanide and Oseltamivir for the treatment of Influenza

Tamarac : Updated

Patients are needed to participate in a clinical research study evaluating oseltamivir and Alternative Control for the treatment of Influenza

Tampa : GSK Investigational Site

A clinical trial seeking patients for a research study for the treatment of Influenza, Human

Tampa : Updated

Patients are needed to participate in a clinical research study evaluating oseltamivir and Alternative Control for the treatment of Influenza

West Palm Beach : Influence Study Site

A clinical research study of Nitazoxanide and Oseltamivir for the treatment of Influenza

Georgia

Atlanta : Atlanta Center for Medical Research

Acute Uncomplicated Seasonal Influenza A in Adults

Columbus : Columbus Regional Research Institute

Do you have a fever, cough, blocked nose, body aches, or fatigue that might be caused by the flu?

Columbus : Columbus Regional Research Institute

FLU Got You Blue? Ask NOW about a clinical research study that you may qualify for.

Columbus : Columbus Regional Research Institute

What do you do when you have the flu?

Atlanta : GSK Investigational Site

A clinical trial seeking patients for a research study for the treatment of Influenza, Human

Atlanta : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human

Canton : Influence Study Site

A clinical research study of Nitazoxanide and Oseltamivir for the treatment of Influenza

Columbus : Influence Study Site

A clinical research study of Nitazoxanide and Oseltamivir for the treatment of Influenza

Idaho

Blackfoot : Influence Study Site

A clinical research study of Nitazoxanide and Oseltamivir for the treatment of Influenza

Illinois

Chicago :

A Phase 4 clinical study for patients with Influenza

Dekalb : 299, Novartis Investigational Site

Patients are needed to participate in a clinical research study evaluating Adjuvanted Quadrivalent Subunit Influenza Virus Vaccine (aQIV) and Non-adjuvanted Trivalent Influenza Vaccine (TIV) / Quadrivalent Influenza Vaccine (QIV) for the treatment of Influenza Virus

Peoria : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human

Indiana

BROWNSBURG : Investigators Research Group, LLC

Clinical trial for Influenza

Iowa

Council Bluffs : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human

Kentucky

Bardstown : 269, Novartis Investigational Site

Patients are needed to participate in a clinical research study evaluating Adjuvanted Quadrivalent Subunit Influenza Virus Vaccine (aQIV) and Non-adjuvanted Trivalent Influenza Vaccine (TIV) / Quadrivalent Influenza Vaccine (QIV) for the treatment of Influenza Virus

Louisville : 226, Novartis Investigational Site

Patients are needed to participate in a clinical research study evaluating Adjuvanted Quadrivalent Subunit Influenza Virus Vaccine (aQIV) and Non-adjuvanted Trivalent Influenza Vaccine (TIV) / Quadrivalent Influenza Vaccine (QIV) for the treatment of Influenza Virus

Louisville : 290, Novartis Investigational Site

Patients are needed to participate in a clinical research study evaluating Adjuvanted Quadrivalent Subunit Influenza Virus Vaccine (aQIV) and Non-adjuvanted Trivalent Influenza Vaccine (TIV) / Quadrivalent Influenza Vaccine (QIV) for the treatment of Influenza Virus

Louisiana

Eunice : Influence Study Site

A clinical research study of Nitazoxanide and Oseltamivir for the treatment of Influenza

Haughton : 265, Novartis Investigational Site

Patients are needed to participate in a clinical research study evaluating Adjuvanted Quadrivalent Subunit Influenza Virus Vaccine (aQIV) and Non-adjuvanted Trivalent Influenza Vaccine (TIV) / Quadrivalent Influenza Vaccine (QIV) for the treatment of Influenza Virus

Lake Charles : Influence Study Site

A clinical research study of Nitazoxanide and Oseltamivir for the treatment of Influenza

Mangham : 408, Novartis Investigational Site

Patients are needed to participate in a clinical research study evaluating Adjuvanted Quadrivalent Subunit Influenza Virus Vaccine (aQIV) and Non-adjuvanted Trivalent Influenza Vaccine (TIV) / Quadrivalent Influenza Vaccine (QIV) for the treatment of Influenza Virus

Monroe : 418, Novartis Investigational SIte

Patients are needed to participate in a clinical research study evaluating Adjuvanted Quadrivalent Subunit Influenza Virus Vaccine (aQIV) and Non-adjuvanted Trivalent Influenza Vaccine (TIV) / Quadrivalent Influenza Vaccine (QIV) for the treatment of Influenza Virus

Maryland

Annapolis : 262, Novartis Investigational site

Patients are needed to participate in a clinical research study evaluating Adjuvanted Quadrivalent Subunit Influenza Virus Vaccine (aQIV) and Non-adjuvanted Trivalent Influenza Vaccine (TIV) / Quadrivalent Influenza Vaccine (QIV) for the treatment of Influenza Virus

Baltimore : SNBL Clinical Pharmacology Center

A clinical trial to evaluate treatments using FGI-101-1A6 for patients with Influenza

Baltimore : Updated

Patients are needed to participate in a clinical research study evaluating oseltamivir and Alternative Control for the treatment of Influenza

Massachusetts

Boston : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human

Boston : Updated

Patients are needed to participate in a clinical research study of oseltamivir [Tamiflu] to evaluate Influenza

Fall River : Influence Study Site

A clinical research study of Nitazoxanide and Oseltamivir for the treatment of Influenza

Springfield : Updated

Patients are needed to participate in a clinical research study evaluating oseltamivir and Alternative Control for the treatment of Influenza

Michigan

Detroit : Updated

Patients are needed to participate in a clinical research study evaluating oseltamivir and Alternative Control for the treatment of Influenza

Rochester : Remedica, LLC

Patients are needed to participate in a clinical research study evaluating Bifidobacterium lactis HN019 and Placebo for the treatment of Influenza

Royal Oak : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human

Troy : Influence Study Site

A clinical research study of Nitazoxanide and Oseltamivir for the treatment of Influenza

Troy : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human

Minnesota

St. Paul : GSK Investigational Site

A clinical trial seeking patients for a research study for the treatment of Influenza, Human

Missouri

Kansas City : GSK Investigational Site

A clinical trial seeking patients for a research study for the treatment of Influenza, Human

St. Louis : GSK Investigational Site

A clinical trial seeking patients for a research study for the treatment of Influenza, Human

St. Louis : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human

Nebraska

Omaha : 402, Novartis Investigational Site

Patients are needed to participate in a clinical research study evaluating Adjuvanted Quadrivalent Subunit Influenza Virus Vaccine (aQIV) and Non-adjuvanted Trivalent Influenza Vaccine (TIV) / Quadrivalent Influenza Vaccine (QIV) for the treatment of Influenza Virus

Omaha : 228, Novartis Investigational Site

Patients are needed to participate in a clinical research study evaluating Adjuvanted Quadrivalent Subunit Influenza Virus Vaccine (aQIV) and Non-adjuvanted Trivalent Influenza Vaccine (TIV) / Quadrivalent Influenza Vaccine (QIV) for the treatment of Influenza Virus

Nevada

Las Vegas : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human

Las Vegas : 286, Novartis Investigational site

Patients are needed to participate in a clinical research study evaluating Adjuvanted Quadrivalent Subunit Influenza Virus Vaccine (aQIV) and Non-adjuvanted Trivalent Influenza Vaccine (TIV) / Quadrivalent Influenza Vaccine (QIV) for the treatment of Influenza Virus

New Jersey

Teaneck : Influence Study Site

A clinical research study of Nitazoxanide and Oseltamivir for the treatment of Influenza

New Mexico

Albuquerque : Influence Study Site

A clinical research study of Nitazoxanide and Oseltamivir for the treatment of Influenza

New York

Brooklyn : 414, Novartis Investigational Site

Patients are needed to participate in a clinical research study evaluating Adjuvanted Quadrivalent Subunit Influenza Virus Vaccine (aQIV) and Non-adjuvanted Trivalent Influenza Vaccine (TIV) / Quadrivalent Influenza Vaccine (QIV) for the treatment of Influenza Virus

Rochester : Influence Study Site

A clinical research study of Nitazoxanide and Oseltamivir for the treatment of Influenza

Syracuse : 264, Novartis Investigational Site

Patients are needed to participate in a clinical research study evaluating Adjuvanted Quadrivalent Subunit Influenza Virus Vaccine (aQIV) and Non-adjuvanted Trivalent Influenza Vaccine (TIV) / Quadrivalent Influenza Vaccine (QIV) for the treatment of Influenza Virus

Syracuse : Updated

Patients are needed to participate in a clinical research study of oseltamivir [Tamiflu] to evaluate Influenza

North Carolina

Cary : PMG Research of Cary

Pediatric flu vaccine research study.

Charlotte : PMG Research of Charlotte

Flu Vaccine – Ages 18-49

Raleigh : PMG Research of Raleigh

Flu Vaccine – Ages 18-49

Raleigh : PMG Research of Raleigh

Flu Vaccine – For Children

Winston-Salem : PMG Research of Winston-Salem

Flu Vaccine – Adults 50 years and older

Winston-Salem : PMG Research of Winston-Salem

Flu Vaccine – For Children

Asheville : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human

Cary : 266, Novartis Investigational Site

Patients are needed to participate in a clinical research study evaluating Adjuvanted Quadrivalent Subunit Influenza Virus Vaccine (aQIV) and Non-adjuvanted Trivalent Influenza Vaccine (TIV) / Quadrivalent Influenza Vaccine (QIV) for the treatment of Influenza Virus

Chapel Hill : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human

Chapel Hill : University of North Carolina

Patients are needed to participate in a clinical research study of FluMist to evaluate Influenza

Charlotte : Updated

Patients are needed to participate in a clinical research study evaluating oseltamivir and Alternative Control for the treatment of Influenza

Clyde : 403, Novartis Investigational Site

Patients are needed to participate in a clinical research study evaluating Adjuvanted Quadrivalent Subunit Influenza Virus Vaccine (aQIV) and Non-adjuvanted Trivalent Influenza Vaccine (TIV) / Quadrivalent Influenza Vaccine (QIV) for the treatment of Influenza Virus

Matthews : Updated

Patients are needed to participate in a clinical research study evaluating oseltamivir and Alternative Control for the treatment of Influenza

Winston-Salem : Influence Study Site

A clinical research study of Nitazoxanide and Oseltamivir for the treatment of Influenza

Ohio

Cleveland : 254, Novartis iNvestigational Site

Patients are needed to participate in a clinical research study evaluating Adjuvanted Quadrivalent Subunit Influenza Virus Vaccine (aQIV) and Non-adjuvanted Trivalent Influenza Vaccine (TIV) / Quadrivalent Influenza Vaccine (QIV) for the treatment of Influenza Virus

Columbus : Influence Study Site

A clinical research study of Nitazoxanide and Oseltamivir for the treatment of Influenza

Columbus : GSK Investigational Site

A clinical trial seeking patients for a research study for the treatment of Influenza, Human

Dayton : 281, Novartis Investigational Site

Patients are needed to participate in a clinical research study evaluating Adjuvanted Quadrivalent Subunit Influenza Virus Vaccine (aQIV) and Non-adjuvanted Trivalent Influenza Vaccine (TIV) / Quadrivalent Influenza Vaccine (QIV) for the treatment of Influenza Virus

Dayton : 281, Novartis Investigational vaccines

Patients are needed to participate in a clinical research study evaluating Adjuvanted Quadrivalent Subunit Influenza Virus Vaccine (aQIV) and Non-adjuvanted Trivalent Influenza Vaccine (TIV) / Quadrivalent Influenza Vaccine (QIV) for the treatment of Influenza Virus

Lyndhurst : Influence Study Site

A clinical research study of Nitazoxanide and Oseltamivir for the treatment of Influenza

Toledo : GSK Investigational Site

A clinical trial seeking patients for a research study for the treatment of Influenza, Human

Toledo : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human

Oklahoma

Tulsa : Influence Study Site

A clinical research study of Nitazoxanide and Oseltamivir for the treatment of Influenza

Pennsylvania

Lansdale : Influence Study Site

A clinical research study of Nitazoxanide and Oseltamivir for the treatment of Influenza

Philadelphia : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human

Philadelphia : Updated

Patients are needed to participate in a clinical research study evaluating oseltamivir and Alternative Control for the treatment of Influenza

Pittsburgh : Influence Study Site

A clinical research study of Nitazoxanide and Oseltamivir for the treatment of Influenza

Pittsburgh : GSK Investigational Site

A clinical trial seeking patients for a research study for the treatment of Influenza, Human

Pittsburgh : Updated

Patients are needed to participate in a clinical research study evaluating oseltamivir and Alternative Control for the treatment of Influenza

Pittsburgh : University of Pittsburgh, Division of Geriatric Medicine

Patients are needed to participate in a clinical research study of High Dose Inactivated Influenza Vaccine and Standard Dose Inactivated Influenza Vaccine to evaluate Influenza

Scottdale : Influence Study Site

A clinical research study of Nitazoxanide and Oseltamivir for the treatment of Influenza

South Carolina

Mt. Pleasant : PMG Research of Charleston

Flu Vaccine – Adults 50 years and older

Mt. Pleasant : PMG Research of Charleston

Flu Vaccine – For Children

Anderson : 220, Novartis Investigational Site

Patients are needed to participate in a clinical research study evaluating Adjuvanted Quadrivalent Subunit Influenza Virus Vaccine (aQIV) and Non-adjuvanted Trivalent Influenza Vaccine (TIV) / Quadrivalent Influenza Vaccine (QIV) for the treatment of Influenza Virus

Spartanburg : 291, Novartis Investigational vaccine

Patients are needed to participate in a clinical research study evaluating Adjuvanted Quadrivalent Subunit Influenza Virus Vaccine (aQIV) and Non-adjuvanted Trivalent Influenza Vaccine (TIV) / Quadrivalent Influenza Vaccine (QIV) for the treatment of Influenza Virus

Spartanburg : Spartanburg Medical Research

Patients are needed to participate in a clinical research study evaluating Flufirvitide 3 and Placebo for Flufirvitide-3 for the treatment of Influenza

South Dakota

Rapid City : Influence Study Site

A clinical research study of Nitazoxanide and Oseltamivir for the treatment of Influenza

Tennessee

Nashville : Clinical Research Associates, Inc.

Upper Respiratory Symptoms Research Study

Columbia : Influence Study Site

A clinical research study of Nitazoxanide and Oseltamivir for the treatment of Influenza

Jackson : Influence Study Site

A clinical research study of Nitazoxanide and Oseltamivir for the treatment of Influenza

Memphis : GSK Investigational Site

A clinical trial seeking patients for a research study for the treatment of Influenza, Human

Memphis : GSK Investigational Site

A clinical trial seeking patients for a research study for the treatment of Influenza, Human

Smyrna : Influence Study Site

A clinical research study of Nitazoxanide and Oseltamivir for the treatment of Influenza

Texas

San Antonio : Sun Research Institute

Are you suffering from Flu-like symptoms?

San Antonio : Endeavor Clinical Trials, PA

Do you have symptoms of the flu?

Beaumont : Influence Study Site

A clinical research study of Nitazoxanide and Oseltamivir for the treatment of Influenza

Bryan : Influence Study Site

A clinical research study of Nitazoxanide and Oseltamivir for the treatment of Influenza

Fort Worth : 247, Novartis Investigational Site

Patients are needed to participate in a clinical research study evaluating Adjuvanted Quadrivalent Subunit Influenza Virus Vaccine (aQIV) and Non-adjuvanted Trivalent Influenza Vaccine (TIV) / Quadrivalent Influenza Vaccine (QIV) for the treatment of Influenza Virus

Houston : Influence Study Site

A clinical research study of Nitazoxanide and Oseltamivir for the treatment of Influenza

Houston : GSK Investigational Site

A clinical trial seeking patients for a research study for the treatment of Influenza, Human

Houston : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human

Irving : Influence Study Site

A clinical research study of Nitazoxanide and Oseltamivir for the treatment of Influenza

Lake Jackson : Influence Study Site

A clinical research study of Nitazoxanide and Oseltamivir for the treatment of Influenza

North Richland Hills : Influence Study Site

A clinical research study of Nitazoxanide and Oseltamivir for the treatment of Influenza

Pharr : Influence Study Site

A clinical research study of Nitazoxanide and Oseltamivir for the treatment of Influenza

Plano : Influence Study Site

A clinical research study of Nitazoxanide and Oseltamivir for the treatment of Influenza

San Antonio : Influence Study Site

A clinical research study of Nitazoxanide and Oseltamivir for the treatment of Influenza

San Antonio : 400, Novartis investigational Site

Patients are needed to participate in a clinical research study evaluating Adjuvanted Quadrivalent Subunit Influenza Virus Vaccine (aQIV) and Non-adjuvanted Trivalent Influenza Vaccine (TIV) / Quadrivalent Influenza Vaccine (QIV) for the treatment of Influenza Virus

Sugar Land : Influence Study Site

A clinical research study of Nitazoxanide and Oseltamivir for the treatment of Influenza

Waco : Influence Study Site

A clinical research study of Nitazoxanide and Oseltamivir for the treatment of Influenza

Utah

Salt Lake City : J. Lewis Research, Inc.

Influenza A Flu Treatment

Layton : 295, Novartis Investigational Site

Patients are needed to participate in a clinical research study evaluating Adjuvanted Quadrivalent Subunit Influenza Virus Vaccine (aQIV) and Non-adjuvanted Trivalent Influenza Vaccine (TIV) / Quadrivalent Influenza Vaccine (QIV) for the treatment of Influenza Virus

Salt Lake City : Influence Study Site

A clinical research study of Nitazoxanide and Oseltamivir for the treatment of Influenza

Salt Lake City : GSK Investigational Site

A clinical trial seeking patients for a research study for the treatment of Influenza, Human

Syracuse : 282, Novartis Investigational Site

Patients are needed to participate in a clinical research study evaluating Adjuvanted Quadrivalent Subunit Influenza Virus Vaccine (aQIV) and Non-adjuvanted Trivalent Influenza Vaccine (TIV) / Quadrivalent Influenza Vaccine (QIV) for the treatment of Influenza Virus

West Haven : 294, Novartis Investigational Site

Patients are needed to participate in a clinical research study evaluating Adjuvanted Quadrivalent Subunit Influenza Virus Vaccine (aQIV) and Non-adjuvanted Trivalent Influenza Vaccine (TIV) / Quadrivalent Influenza Vaccine (QIV) for the treatment of Influenza Virus

Virginia

Newport News : Health Research of Hampton Roads, Inc.

Influenza (Flu) Research – Adults

Charlottesville : Influence Study Site

A clinical research study of Nitazoxanide and Oseltamivir for the treatment of Influenza

Midlothian : Influence Study Site

A clinical research study of Nitazoxanide and Oseltamivir for the treatment of Influenza

Roanoke : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human

Washington

Port Orchard : Influence Study Site

A clinical research study of Nitazoxanide and Oseltamivir for the treatment of Influenza

Seattle : Updated

Patients are needed to participate in a clinical research study of oseltamivir [Tamiflu] to evaluate Influenza

Spokane : Influence Study Site

A clinical research study of Nitazoxanide and Oseltamivir for the treatment of Influenza

Spokane : Influence Study Site

A clinical research study of Nitazoxanide and Oseltamivir for the treatment of Influenza

Wisconsin

La Crosse : Influence Study Site

A clinical research study of Nitazoxanide and Oseltamivir for the treatment of Influenza

Milwaukee : GSK Investigational Site

A clinical trial seeking patients for a research study for the treatment of Influenza, Human

Argentina

Buenos Aires : Updated

Patients are needed to participate in a clinical research study evaluating oseltamivir and Alternative Control for the treatment of Influenza

Buenos Aires : Updated

Patients are needed to participate in a clinical research study evaluating oseltamivir and Alternative Control for the treatment of Influenza

Ciudad Autonoma Buenos Aires : Updated

Patients are needed to participate in a clinical research study evaluating oseltamivir and Alternative Control for the treatment of Influenza

Ciudad Autonoma Buenos Aires : Updated

Patients are needed to participate in a clinical research study evaluating oseltamivir and Alternative Control for the treatment of Influenza

La Plata : Updated

Patients are needed to participate in a clinical research study evaluating oseltamivir and Alternative Control for the treatment of Influenza

Santa Fe : Updated

Patients are needed to participate in a clinical research study evaluating oseltamivir and Alternative Control for the treatment of Influenza

Australia

Adelaide : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human

Adelaide : CMAX, a division of IDT Australia Limited

Patients are needed to participate in a clinical research study evaluating VAX2012Q and Placebo for the treatment of Influenza

Bedford Park : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human

Heidelberg : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human

Herston : Q-Pharm Pty Limited

Patients are needed to participate in a clinical research study evaluating VAX2012Q and Placebo for the treatment of Influenza

Melbourne : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human

Belgium

Brussel : Updated

Patients are needed to participate in a clinical research study of oseltamivir [Tamiflu] to evaluate Influenza

Brussels :

A Phase 2 clinical study for patients with Influenza

Brussels :

A Phase 2 clinical study for patients with Influenza

Bruxelles : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human

Bruxelles : Updated

Patients are needed to participate in a clinical research study evaluating oseltamivir and Alternative Control for the treatment of Influenza

Bruxelles : Updated

Patients are needed to participate in a clinical research study evaluating oseltamivir and Alternative Control for the treatment of Influenza

Bruxelles : Updated

Patients are needed to participate in a clinical research study of oseltamivir [Tamiflu] to evaluate Influenza

Leuven :

A Phase 2 clinical study for patients with Influenza

Leuven : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human

Leuven : Updated

Patients are needed to participate in a clinical research study of oseltamivir [Tamiflu] to evaluate Influenza

Yvoir :

A Phase 2 clinical study for patients with Influenza

Brazil

Rio de Janeiro : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human

Rio de Janeiro : Updated

Patients are needed to participate in a clinical research study evaluating oseltamivir and Alternative Control for the treatment of Influenza

Sao Paulo : Updated

Patients are needed to participate in a clinical research study evaluating oseltamivir and Alternative Control for the treatment of Influenza

Sao Paulo : Updated

Patients are needed to participate in a clinical research study evaluating oseltamivir and Alternative Control for the treatment of Influenza

São Paulo : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human

Bulgaria

Plovdiv : Updated

Patients are needed to participate in a clinical research study evaluating oseltamivir and Alternative Control for the treatment of Influenza

Canada

Calgary : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human

Calgary : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human

Halifax : QEII Health Science Centre

A clinical study for patients with Influenza

Hamilton : McMaster

A clinical study for patients with Influenza

Hamilton : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human

Langley : Influence Study Site

A clinical research study of Nitazoxanide and Oseltamivir for the treatment of Influenza

London :

A Phase 2 clinical study for patients with Influenza

Mirabel : Influence Study Site

A clinical research study of Nitazoxanide and Oseltamivir for the treatment of Influenza

Montreal : MUCH

A clinical study for patients with Influenza

Montreal : Updated

Patients are needed to participate in a clinical research study of oseltamivir [Tamiflu] to evaluate Influenza

Niagara Falls : Influence Study Site

A clinical research study of Nitazoxanide and Oseltamivir for the treatment of Influenza

Ottawa : Ottawa General

A clinical study for patients with Influenza

Ottawa :

A Phase 2 clinical study for patients with Influenza

Ottawa : Updated

Patients are needed to participate in a clinical research study of oseltamivir [Tamiflu] to evaluate Influenza

Pierrefonds : MUHC-Vaccine Study Centre

A Phase 2 clinical study for patients with Virus Diseases, RNA Virus Infections, Respiratory Tract Diseases or Respiratory Tract Infections

Quebec : CHUl/CHUQ

A clinical study for patients with Influenza

Québec : Centre de recherche-CHU de Québec

A Phase 2 clinical study for patients with Virus Diseases, RNA Virus Infections, Respiratory Tract Diseases or Respiratory Tract Infections

Québec : inVentiv Health Clinique

A Phase 2 clinical study for patients with Virus Diseases, RNA Virus Infections, Respiratory Tract Diseases or Respiratory Tract Infections

Saint John : Saint John Regional Hospital

A clinical study for patients with Influenza

Sainte-foy :

A Phase 2 clinical study for patients with Influenza

Sherbrooke : CHUS

A clinical study for patients with Influenza

Surrey : Influence Study Site

A clinical research study of Nitazoxanide and Oseltamivir for the treatment of Influenza

Surrey : Fraser Health Authority

A clinical trial to evaluate treatments for patients with Influenza

Toronto : Mount Sinai

A clinical study for patients with Influenza

Toronto : Influence Study Site

A clinical research study of Nitazoxanide and Oseltamivir for the treatment of Influenza

Toronto : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human

Toronto : 182,Novartis Investigational Site

Patients are needed to participate in a clinical research study evaluating Adjuvanted Quadrivalent Subunit Influenza Virus Vaccine (aQIV) and Non-adjuvanted Trivalent Influenza Vaccine (TIV) / Quadrivalent Influenza Vaccine (QIV) for the treatment of Influenza Virus

Toronto : Updated

Patients are needed to participate in a clinical research study of oseltamivir [Tamiflu] to evaluate Influenza

Trois-Rivières : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human

Vancouver : Vancouver General

A clinical study for patients with Influenza

Vancouver :

A Phase 2 clinical study for patients with Influenza

Victoria :

A Phase 2 clinical study for patients with Influenza

Chile

Santiago : Updated

Patients are needed to participate in a clinical research study evaluating oseltamivir and Alternative Control for the treatment of Influenza

Viña del Mar Valparaiso : Updated

Patients are needed to participate in a clinical research study evaluating oseltamivir and Alternative Control for the treatment of Influenza

China

Beijing : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human

Chengdu : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human

Chongqing : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human

Guangzhou : Guangzhou Institute of Respiratory Disease

A clinical trial seeking patients for a research study for the treatment of Influenza

Guangzhou : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human

Hangzhou : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human

Nanchang : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human

Shanghai : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human

Colombia

Barranquilla : Updated

Patients are needed to participate in a clinical research study evaluating oseltamivir and Alternative Control for the treatment of Influenza

Bogota : Updated

Patients are needed to participate in a clinical research study evaluating oseltamivir and Alternative Control for the treatment of Influenza

Cali : Updated

Patients are needed to participate in a clinical research study evaluating oseltamivir and Alternative Control for the treatment of Influenza

Floridablanca : Updated

Patients are needed to participate in a clinical research study evaluating oseltamivir and Alternative Control for the treatment of Influenza

Czech Republic

Brno - Bohunice : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human

Ostrava :

A Phase 2 clinical study for patients with Influenza

Praha 5 : Updated

Patients are needed to participate in a clinical research study evaluating oseltamivir and Alternative Control for the treatment of Influenza

Zlin : Updated

Patients are needed to participate in a clinical research study evaluating oseltamivir and Alternative Control for the treatment of Influenza

Denmark

Odense C : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human

Estonia

Tallinn : Updated

Patients are needed to participate in a clinical research study evaluating oseltamivir and Alternative Control for the treatment of Influenza

Tallinn : Updated

Patients are needed to participate in a clinical research study evaluating oseltamivir and Alternative Control for the treatment of Influenza

Tartu : Updated

Patients are needed to participate in a clinical research study evaluating oseltamivir and Alternative Control for the treatment of Influenza

Finland

Kokkola : 005, Novartis Investigational Site

Patients are needed to participate in a clinical research study evaluating Adjuvanted Quadrivalent Subunit Influenza Virus Vaccine (aQIV) and Non-adjuvanted Trivalent Influenza Vaccine (TIV) / Quadrivalent Influenza Vaccine (QIV) for the treatment of Influenza Virus

Seinäjoki : 008, Novartis Investigational Site

Patients are needed to participate in a clinical research study evaluating Adjuvanted Quadrivalent Subunit Influenza Virus Vaccine (aQIV) and Non-adjuvanted Trivalent Influenza Vaccine (TIV) / Quadrivalent Influenza Vaccine (QIV) for the treatment of Influenza Virus

France

Bron :

A Phase 4 clinical study for patients with Influenza

La Roche Sur Yon :

A Phase 2 clinical study for patients with Influenza

Limoges cedex : GSK Investigational Site

A clinical trial seeking patients for a research study for the treatment of Influenza, Human

Limoges cedex : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human

Orléans cedex 2 : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human

Paris : Institut National de la Santé Et de la Recherche Médicale

A clinical research study of nasopharyngeal sample for the treatment of Influenza-like Illness

Poitiers Cedex : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human

Tours cedex 9 : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human

Germany

Berlin : Updated

Patients are needed to participate in a clinical research study of oseltamivir [Tamiflu] to evaluate Influenza

Erlangen : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human

Frankfurt : Updated

Patients are needed to participate in a clinical research study of oseltamivir [Tamiflu] to evaluate Influenza

Muenchen : Updated

Patients are needed to participate in a clinical research study evaluating oseltamivir and Alternative Control for the treatment of Influenza

Muenster : Updated

Patients are needed to participate in a clinical research study evaluating oseltamivir and Alternative Control for the treatment of Influenza

Münster : Updated

Patients are needed to participate in a clinical research study of oseltamivir [Tamiflu] to evaluate Influenza

Regensburg : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human

Tübingen : Updated

Patients are needed to participate in a clinical research study of oseltamivir [Tamiflu] to evaluate Influenza

Greece

Chaidari : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human

Goudi, Athens : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human

Guatemala

Ciudad de Guatemala : Updated

Patients are needed to participate in a clinical research study evaluating oseltamivir and Alternative Control for the treatment of Influenza

Ciudad de Guatemala : Updated

Patients are needed to participate in a clinical research study evaluating oseltamivir and Alternative Control for the treatment of Influenza

Guatemala City : Updated

Patients are needed to participate in a clinical research study evaluating oseltamivir and Alternative Control for the treatment of Influenza

Guatemala City : Updated

Patients are needed to participate in a clinical research study evaluating oseltamivir and Alternative Control for the treatment of Influenza

Hong Kong

Kwun Tong : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human

Shatin :

A Phase 4 clinical study for patients with Influenza

Tuen Mun : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human

Hungary

Budapest : Updated

Patients are needed to participate in a clinical research study evaluating oseltamivir and Alternative Control for the treatment of Influenza

Debrecen : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human

Gyor : Updated

Patients are needed to participate in a clinical research study evaluating oseltamivir and Alternative Control for the treatment of Influenza

Gyula : Updated

Patients are needed to participate in a clinical research study evaluating oseltamivir and Alternative Control for the treatment of Influenza

Kaposvár : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human

Szekesfehervar : Updated

Patients are needed to participate in a clinical research study evaluating oseltamivir and Alternative Control for the treatment of Influenza

Székesfehérvár : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human

Szolnok :

A Phase 2 clinical study for patients with Influenza

Szolnok : Updated

Patients are needed to participate in a clinical research study evaluating oseltamivir and Alternative Control for the treatment of Influenza

India

Civil Lines : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human

Lucknow : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human

Pune : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human

Trivandrum : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human

Israel

Haifa : Updated

Patients are needed to participate in a clinical research study of oseltamivir [Tamiflu] to evaluate Influenza

Jerusalem : Updated

Patients are needed to participate in a clinical research study evaluating oseltamivir and Alternative Control for the treatment of Influenza

Jerusalem : Updated

Patients are needed to participate in a clinical research study of oseltamivir [Tamiflu] to evaluate Influenza

Petach Tikva : Updated

Patients are needed to participate in a clinical research study evaluating oseltamivir and Alternative Control for the treatment of Influenza

Petach Tikva : Updated

Patients are needed to participate in a clinical research study of oseltamivir [Tamiflu] to evaluate Influenza

Ramat-Gan : Updated

Patients are needed to participate in a clinical research study of oseltamivir [Tamiflu] to evaluate Influenza

Tel Aviv : Updated

Patients are needed to participate in a clinical research study of oseltamivir [Tamiflu] to evaluate Influenza

Tel Hashomer : Updated

Patients are needed to participate in a clinical research study evaluating oseltamivir and Alternative Control for the treatment of Influenza

Tel-Aviv : Clinical Research Center, Tel-Aviv Sourasky Medical Center

A clinical trial to evaluate treatments using M-001 for patients with Influenza

Italy

Brescia : Updated

Patients are needed to participate in a clinical research study evaluating oseltamivir and Alternative Control for the treatment of Influenza

Florence : 030, Novartis Investigational Site

Patients are needed to participate in a clinical research study evaluating Adjuvanted Quadrivalent Subunit Influenza Virus Vaccine (aQIV) and Non-adjuvanted Trivalent Influenza Vaccine (TIV) / Quadrivalent Influenza Vaccine (QIV) for the treatment of Influenza Virus

Genova : 023, Novartis Investigational Site

Patients are needed to participate in a clinical research study evaluating Adjuvanted Quadrivalent Subunit Influenza Virus Vaccine (aQIV) and Non-adjuvanted Trivalent Influenza Vaccine (TIV) / Quadrivalent Influenza Vaccine (QIV) for the treatment of Influenza Virus

Milano : Updated

Patients are needed to participate in a clinical research study of oseltamivir [Tamiflu] to evaluate Influenza

Monza : Updated

Patients are needed to participate in a clinical research study evaluating oseltamivir and Alternative Control for the treatment of Influenza

Monza : Updated

Patients are needed to participate in a clinical research study of oseltamivir [Tamiflu] to evaluate Influenza

Napoli : 025, Novartis Investigational Site

Patients are needed to participate in a clinical research study evaluating Adjuvanted Quadrivalent Subunit Influenza Virus Vaccine (aQIV) and Non-adjuvanted Trivalent Influenza Vaccine (TIV) / Quadrivalent Influenza Vaccine (QIV) for the treatment of Influenza Virus

Novara : 021, Novartis Investigational Site

Patients are needed to participate in a clinical research study evaluating Adjuvanted Quadrivalent Subunit Influenza Virus Vaccine (aQIV) and Non-adjuvanted Trivalent Influenza Vaccine (TIV) / Quadrivalent Influenza Vaccine (QIV) for the treatment of Influenza Virus

Parma : Updated

Patients are needed to participate in a clinical research study evaluating oseltamivir and Alternative Control for the treatment of Influenza

Pavia : Updated

Patients are needed to participate in a clinical research study evaluating oseltamivir and Alternative Control for the treatment of Influenza

Pisa : 024, Novartis Investigational Site

Patients are needed to participate in a clinical research study evaluating Adjuvanted Quadrivalent Subunit Influenza Virus Vaccine (aQIV) and Non-adjuvanted Trivalent Influenza Vaccine (TIV) / Quadrivalent Influenza Vaccine (QIV) for the treatment of Influenza Virus

Roma : Updated

Patients are needed to participate in a clinical research study evaluating oseltamivir and Alternative Control for the treatment of Influenza

Roma : Updated

Patients are needed to participate in a clinical research study evaluating oseltamivir and Alternative Control for the treatment of Influenza

Roma : Updated

Patients are needed to participate in a clinical research study of oseltamivir [Tamiflu] to evaluate Influenza

Japan

Fukuoka :

A clinical trial to evaluate treatments using ASP7374 for patients with Influenza or Vaccine

Yamanashi : GSK Investigational Site

A clinical trial seeking patients for a research study for the treatment of Influenza, Human

Kenya

Kisumu : KEMRI/CDC- IEIP surveillance-Asembo

A clinical trial seeking patients for a research study for the treatment of Influenza, Influenza Like Illness or Severe Acute Respiratory Illness

Nairobi : KEMRI/CDC IEIP surveillance- Kibera

A clinical trial seeking patients for a research study for the treatment of Influenza, Influenza Like Illness or Severe Acute Respiratory Illness

Korea, Republic of

Gyeonggi : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human

Latvia

Riga : Updated

Patients are needed to participate in a clinical research study evaluating oseltamivir and Alternative Control for the treatment of Influenza

Lithuania

Kaunas : Updated

Patients are needed to participate in a clinical research study evaluating oseltamivir and Alternative Control for the treatment of Influenza

Klaipeda : Updated

Patients are needed to participate in a clinical research study evaluating oseltamivir and Alternative Control for the treatment of Influenza

Siauliai : Updated

Patients are needed to participate in a clinical research study evaluating oseltamivir and Alternative Control for the treatment of Influenza

Vilnius : Updated

Patients are needed to participate in a clinical research study evaluating oseltamivir and Alternative Control for the treatment of Influenza

Mexico

Colonia Chamilpa, Cuernavaca : 03, Centro Médico Universitario

A clinical trial to evaluate treatments using Adjuvanted Trivalent Influenza Vaccine, 1 dose for non-naive subjects (day 1), two doses for naive subjects (day 1 and day 29) and Non-adjuvanted Trivalent Influenza Vaccine, 1 dose for non-naive subjects (day 1), two doses for naive subjects (day 1 and day 29). for patients with Influenza

Cuautitlan Izcalli : Updated

Patients are needed to participate in a clinical research study evaluating oseltamivir and Alternative Control for the treatment of Influenza

Guadalajara : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human

Guadalajara : Updated

Patients are needed to participate in a clinical research study evaluating oseltamivir and Alternative Control for the treatment of Influenza

Mexico : Updated

Patients are needed to participate in a clinical research study evaluating oseltamivir and Alternative Control for the treatment of Influenza

Mexico : Updated

Patients are needed to participate in a clinical research study evaluating oseltamivir and Alternative Control for the treatment of Influenza

Mexico, Distrito Federal : Updated

Patients are needed to participate in a clinical research study evaluating oseltamivir and Alternative Control for the treatment of Influenza

Monterrey : Updated

Patients are needed to participate in a clinical research study evaluating oseltamivir and Alternative Control for the treatment of Influenza

Zapopan : Updated

Patients are needed to participate in a clinical research study evaluating oseltamivir and Alternative Control for the treatment of Influenza

Netherlands

Nijmegen : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human

New Zealand

Auckland : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human

Auckland : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human

Auckland : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human

Christchurch : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human

Hastings : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human

Newtown : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human

Norway

Bergen : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human

Trondheim : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human

Poland

Bialystok : Updated

Patients are needed to participate in a clinical research study evaluating oseltamivir and Alternative Control for the treatment of Influenza

Debica : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human

Debica : 040, Novartis Investigational Site

Patients are needed to participate in a clinical research study evaluating Adjuvanted Quadrivalent Subunit Influenza Virus Vaccine (aQIV) and Non-adjuvanted Trivalent Influenza Vaccine (TIV) / Quadrivalent Influenza Vaccine (QIV) for the treatment of Influenza Virus

Gdansk : Updated

Patients are needed to participate in a clinical research study of oseltamivir [Tamiflu] to evaluate Influenza

Katowice : 042, Novartis Investigational Site

Patients are needed to participate in a clinical research study evaluating Adjuvanted Quadrivalent Subunit Influenza Virus Vaccine (aQIV) and Non-adjuvanted Trivalent Influenza Vaccine (TIV) / Quadrivalent Influenza Vaccine (QIV) for the treatment of Influenza Virus

Krakow :

A Phase 4 clinical study for patients with Influenza

Leczna : 052, Novartis Investigational Site

Patients are needed to participate in a clinical research study evaluating Adjuvanted Quadrivalent Subunit Influenza Virus Vaccine (aQIV) and Non-adjuvanted Trivalent Influenza Vaccine (TIV) / Quadrivalent Influenza Vaccine (QIV) for the treatment of Influenza Virus

Lodz : 048, Novartis Investigational Site

Patients are needed to participate in a clinical research study evaluating Adjuvanted Quadrivalent Subunit Influenza Virus Vaccine (aQIV) and Non-adjuvanted Trivalent Influenza Vaccine (TIV) / Quadrivalent Influenza Vaccine (QIV) for the treatment of Influenza Virus

Lodz : Updated

Patients are needed to participate in a clinical research study evaluating oseltamivir and Alternative Control for the treatment of Influenza

Lubartow : 049, Novartis Investigational Site

Patients are needed to participate in a clinical research study evaluating Adjuvanted Quadrivalent Subunit Influenza Virus Vaccine (aQIV) and Non-adjuvanted Trivalent Influenza Vaccine (TIV) / Quadrivalent Influenza Vaccine (QIV) for the treatment of Influenza Virus

Oborniki Slaskie : 051, Novartis Investigational Site

Patients are needed to participate in a clinical research study evaluating Adjuvanted Quadrivalent Subunit Influenza Virus Vaccine (aQIV) and Non-adjuvanted Trivalent Influenza Vaccine (TIV) / Quadrivalent Influenza Vaccine (QIV) for the treatment of Influenza Virus

Olsztyn : Updated

Patients are needed to participate in a clinical research study of oseltamivir [Tamiflu] to evaluate Influenza

Osielsko : 046, Novartis Investigational Site

Patients are needed to participate in a clinical research study evaluating Adjuvanted Quadrivalent Subunit Influenza Virus Vaccine (aQIV) and Non-adjuvanted Trivalent Influenza Vaccine (TIV) / Quadrivalent Influenza Vaccine (QIV) for the treatment of Influenza Virus

Siemianowice Slaskie : 043, Novartis Investigational Site

Patients are needed to participate in a clinical research study evaluating Adjuvanted Quadrivalent Subunit Influenza Virus Vaccine (aQIV) and Non-adjuvanted Trivalent Influenza Vaccine (TIV) / Quadrivalent Influenza Vaccine (QIV) for the treatment of Influenza Virus

Szczecin : Updated

Patients are needed to participate in a clinical research study of oseltamivir [Tamiflu] to evaluate Influenza

Tarnow : 047, Novartis Investigational Site

Patients are needed to participate in a clinical research study evaluating Adjuvanted Quadrivalent Subunit Influenza Virus Vaccine (aQIV) and Non-adjuvanted Trivalent Influenza Vaccine (TIV) / Quadrivalent Influenza Vaccine (QIV) for the treatment of Influenza Virus

Warszawa : 041, Novartis Investigational Site

Patients are needed to participate in a clinical research study evaluating Adjuvanted Quadrivalent Subunit Influenza Virus Vaccine (aQIV) and Non-adjuvanted Trivalent Influenza Vaccine (TIV) / Quadrivalent Influenza Vaccine (QIV) for the treatment of Influenza Virus

Warszawa : 050, Novartis Investigational Site

Patients are needed to participate in a clinical research study evaluating Adjuvanted Quadrivalent Subunit Influenza Virus Vaccine (aQIV) and Non-adjuvanted Trivalent Influenza Vaccine (TIV) / Quadrivalent Influenza Vaccine (QIV) for the treatment of Influenza Virus

Wola : 045, Novartis Investigational Site

Patients are needed to participate in a clinical research study evaluating Adjuvanted Quadrivalent Subunit Influenza Virus Vaccine (aQIV) and Non-adjuvanted Trivalent Influenza Vaccine (TIV) / Quadrivalent Influenza Vaccine (QIV) for the treatment of Influenza Virus

Wroclaw : 044, Novartis Investigational Site

Patients are needed to participate in a clinical research study evaluating Adjuvanted Quadrivalent Subunit Influenza Virus Vaccine (aQIV) and Non-adjuvanted Trivalent Influenza Vaccine (TIV) / Quadrivalent Influenza Vaccine (QIV) for the treatment of Influenza Virus

Zabrze : Updated

Patients are needed to participate in a clinical research study of oseltamivir [Tamiflu] to evaluate Influenza

Puerto Rico

Ponce : 257, Novartis Investigational Site

Patients are needed to participate in a clinical research study evaluating Adjuvanted Quadrivalent Subunit Influenza Virus Vaccine (aQIV) and Non-adjuvanted Trivalent Influenza Vaccine (TIV) / Quadrivalent Influenza Vaccine (QIV) for the treatment of Influenza Virus

Russian Federation

Barnaul : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human

Barnaul : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human

Saint-Petersburg : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human

Saratov :

Patients are needed to participate in a clinical research study evaluating Arbidol (Umifenovir) and placebo for the treatment of Influenza

Slovakia

Bratislava : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human

South Africa

Bloemfontein : Updated

Patients are needed to participate in a clinical research study evaluating oseltamivir and Alternative Control for the treatment of Influenza

Durban : Updated

Patients are needed to participate in a clinical research study evaluating oseltamivir and Alternative Control for the treatment of Influenza

Johannesburg : Updated

Patients are needed to participate in a clinical research study evaluating oseltamivir and Alternative Control for the treatment of Influenza

Johannesburg : Updated

Patients are needed to participate in a clinical research study of oseltamivir [Tamiflu] to evaluate Influenza

Johannesburg : Updated

Patients are needed to participate in a clinical research study of oseltamivir [Tamiflu] to evaluate Influenza

Middelburg : Updated

Patients are needed to participate in a clinical research study evaluating oseltamivir and Alternative Control for the treatment of Influenza

Paarl : Updated

Patients are needed to participate in a clinical research study evaluating oseltamivir and Alternative Control for the treatment of Influenza

Port Elizabeth : Updated

Patients are needed to participate in a clinical research study evaluating oseltamivir and Alternative Control for the treatment of Influenza

Pretoria : Updated

Patients are needed to participate in a clinical research study evaluating oseltamivir and Alternative Control for the treatment of Influenza

Pretoria : Updated

Patients are needed to participate in a clinical research study evaluating oseltamivir and Alternative Control for the treatment of Influenza

Soweto : Updated

Patients are needed to participate in a clinical research study evaluating oseltamivir and Alternative Control for the treatment of Influenza

Tygerberg; Cape Town : Updated

Patients are needed to participate in a clinical research study evaluating oseltamivir and Alternative Control for the treatment of Influenza

Welkom : Updated

Patients are needed to participate in a clinical research study evaluating oseltamivir and Alternative Control for the treatment of Influenza

Spain

Alicante : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human

Badalona : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human

Barcelona :

A Phase 2 clinical study for patients with Influenza

Barcelona :

A Phase 2 clinical study for patients with Influenza

Barcelona : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human

Barcelona : Updated

Patients are needed to participate in a clinical research study of oseltamivir [Tamiflu] to evaluate Influenza

Granada :

A Phase 2 clinical study for patients with Influenza

Granada : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human

Granada : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human

Granada : 074, Novartis Investigational Site

Patients are needed to participate in a clinical research study evaluating Adjuvanted Quadrivalent Subunit Influenza Virus Vaccine (aQIV) and Non-adjuvanted Trivalent Influenza Vaccine (TIV) / Quadrivalent Influenza Vaccine (QIV) for the treatment of Influenza Virus

Hospitalet de Llobregat :

A Phase 2 clinical study for patients with Influenza

L'Hospitalet de Llobregat : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human

Madrid : GSK Investigational Site

A clinical trial seeking patients for a research study for the treatment of Influenza, Human

Madrid :

A Phase 2 clinical study for patients with Influenza

Madrid : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human

Madrid : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human

Madrid : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human

Madrid : 077, Novartis Investigational Site

Patients are needed to participate in a clinical research study evaluating Adjuvanted Quadrivalent Subunit Influenza Virus Vaccine (aQIV) and Non-adjuvanted Trivalent Influenza Vaccine (TIV) / Quadrivalent Influenza Vaccine (QIV) for the treatment of Influenza Virus

Madrid : Updated

Patients are needed to participate in a clinical research study evaluating oseltamivir and Alternative Control for the treatment of Influenza

Madrid : Updated

Patients are needed to participate in a clinical research study evaluating oseltamivir and Alternative Control for the treatment of Influenza

Madrid : Updated

Patients are needed to participate in a clinical research study evaluating oseltamivir and Alternative Control for the treatment of Influenza

Madrid : Updated

Patients are needed to participate in a clinical research study of oseltamivir [Tamiflu] to evaluate Influenza

Madrid : Updated

Patients are needed to participate in a clinical research study of oseltamivir [Tamiflu] to evaluate Influenza

Malaga : 79, Novartis Investigational Site

Patients are needed to participate in a clinical research study evaluating Adjuvanted Quadrivalent Subunit Influenza Virus Vaccine (aQIV) and Non-adjuvanted Trivalent Influenza Vaccine (TIV) / Quadrivalent Influenza Vaccine (QIV) for the treatment of Influenza Virus

Mataro :

A Phase 2 clinical study for patients with Influenza

Murcia : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human

Pama de Mallorca : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human

Sabadell : 80, Novartis Investigational Site

Patients are needed to participate in a clinical research study evaluating Adjuvanted Quadrivalent Subunit Influenza Virus Vaccine (aQIV) and Non-adjuvanted Trivalent Influenza Vaccine (TIV) / Quadrivalent Influenza Vaccine (QIV) for the treatment of Influenza Virus

Santiago : 075, Novartis Investigational Site

Patients are needed to participate in a clinical research study evaluating Adjuvanted Quadrivalent Subunit Influenza Virus Vaccine (aQIV) and Non-adjuvanted Trivalent Influenza Vaccine (TIV) / Quadrivalent Influenza Vaccine (QIV) for the treatment of Influenza Virus

Terrassa :

A Phase 2 clinical study for patients with Influenza

Valencia :

A Phase 2 clinical study for patients with Influenza

Taiwan

Banciao : 343, Novartis Investigational Site

Patients are needed to participate in a clinical research study evaluating Adjuvanted Quadrivalent Subunit Influenza Virus Vaccine (aQIV) and Non-adjuvanted Trivalent Influenza Vaccine (TIV) / Quadrivalent Influenza Vaccine (QIV) for the treatment of Influenza Virus

Taichung : 345, Novartis Investigational Site

Patients are needed to participate in a clinical research study evaluating Adjuvanted Quadrivalent Subunit Influenza Virus Vaccine (aQIV) and Non-adjuvanted Trivalent Influenza Vaccine (TIV) / Quadrivalent Influenza Vaccine (QIV) for the treatment of Influenza Virus

Taichung : 344, Novartis Investigational Site

Patients are needed to participate in a clinical research study evaluating Adjuvanted Quadrivalent Subunit Influenza Virus Vaccine (aQIV) and Non-adjuvanted Trivalent Influenza Vaccine (TIV) / Quadrivalent Influenza Vaccine (QIV) for the treatment of Influenza Virus

Tainan : National Cheng Kung University Hospital

Patients are needed to participate in a clinical research study evaluating Pandemic Influenza Vaccine (H5N1) for the treatment of Pandemic Influenza

Taipei : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human

Taipei : National Taiwan University Hospital

Patients are needed to participate in a clinical research study evaluating AdimFlu-V for the treatment of Influenza

Taipei City : 341, Novartis Investigational Site

Patients are needed to participate in a clinical research study evaluating Adjuvanted Quadrivalent Subunit Influenza Virus Vaccine (aQIV) and Non-adjuvanted Trivalent Influenza Vaccine (TIV) / Quadrivalent Influenza Vaccine (QIV) for the treatment of Influenza Virus

Taipei City : 340, Novartis Investigational Site

Patients are needed to participate in a clinical research study evaluating Adjuvanted Quadrivalent Subunit Influenza Virus Vaccine (aQIV) and Non-adjuvanted Trivalent Influenza Vaccine (TIV) / Quadrivalent Influenza Vaccine (QIV) for the treatment of Influenza Virus

Taoyuan : 342, Novartis Investigational Site

Patients are needed to participate in a clinical research study evaluating Adjuvanted Quadrivalent Subunit Influenza Virus Vaccine (aQIV) and Non-adjuvanted Trivalent Influenza Vaccine (TIV) / Quadrivalent Influenza Vaccine (QIV) for the treatment of Influenza Virus

Taoyuan County : Chang Gung Memorial Hospital at Linkuo

Patients are needed to participate in a clinical research study evaluating AdimFlu-V for the treatment of Influenza

United Kingdom

Cardiff : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human

London :

A clinical trial seeking patients for a research study for the treatment of Influenza

Manchester : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human